M. Young

Most-cited papers

1. Minimal Compared With Standard Monitoring During Sofosbuvir-Based Hepatitis C Treatment: A Randomized Controlled Trial

   J. S. Davis, M. Young, C. Marshall, J. Tate-Baker +5 more

   2020Open Forum Infectious Diseases7 citations Open access

   Semantic Scholar

   Save

2. Adjunctive moxibustion treatment for tuberculosis: A randomised clinical trial investigating potential efficacy and comparative safety

   Hood Ibanda, F. Mubiru, Rogers Musiba, S. Itaya +3 more

   2018European Journal of Integrative Medicine6 citations

   Semantic Scholar

   Save

3. Urgent global action is needed on multi drug-resistant tuberculosis (MDR-TB) – can small cone moxa contribute to a global response?

   M. Young, J. Craig

   2020European Journal of Integrative Medicine4 citations

   Semantic Scholar

   Save

4. A multi-centre, double-blind, parallel-group comparative study to assess the efficacy and safety of Hepagene™ and Engerix®B in subjects with an proven inadequate response to prior vaccination

   A. Williams, M. Young

   19983 citations

   Semantic Scholar

   Save

5. A multi-centre, double-blind, parallel-group comparative study to assess the efficacy and safety of a single dose of either Hepagene™ or Engerix®B in subjects with an inadequate response to previous vaccination with an S-containing hepatitis B vaccine

   A. Williams, M. Young

   19981 citations

   Semantic Scholar

   Save